SHAUNA JOHNSON

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner THOMASTON, GA NPI 1366933558

General Payments — all program years on this page

$3,945.62

Category: General Payments
Program years: PY2021–2024
Record count: 207
As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,042.54 across 54 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of payment	Amount	Records
Food and Beverage	$1,015.27	53
Education	$27.27	1

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entity	Amount	Records
Otsuka America Pharmaceutical, Inc.	$186.63	11
Neurocrine BioSciences, Inc.	$186.27	10
Indivior Inc.	$161.78	5
Teva Pharmaceuticals USA, Inc.	$130.75	11
ABBVIE INC.	$115.31	6
ITI, Inc.	$81.89	4
Lundbeck LLC	$74.08	3
Supernus Pharmaceuticals, Inc.	$37.93	1
E.R. Squibb & Sons, L.L.C.	$27.27	1
Janssen Pharmaceuticals, Inc	$21.87	1
Alkermes, Inc.	$18.76	1

By program year

Program year	Amount	Records
2021	$913.96	55
2022	$346.17	16
2023	$1,642.95	82
2024	$1,042.54	54

Records — PY2024 (54)

Record ID	Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Source
1077996426	Janssen Pharmaceuticals, Inc	$21.87	08/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1101746975	E.R. Squibb & Sons, L.L.C.	$27.27	10/29/2024	Education	Undisputed	01/23/2026	View at CMS
1107414068	ABBVIE INC.	$13.58	01/26/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1107414070	ABBVIE INC.	$32.34	03/20/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1107414072	ABBVIE INC.	$16.11	05/02/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1107414074	ABBVIE INC.	$19.03	06/26/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1107414076	ABBVIE INC.	$18.75	07/25/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1107414078	ABBVIE INC.	$15.50	10/03/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1119105854	Otsuka America Pharmaceutical, Inc.	$28.64	02/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1119105856	Otsuka America Pharmaceutical, Inc.	$21.61	02/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1119105858	Otsuka America Pharmaceutical, Inc.	$34.72	02/28/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1119105860	Otsuka America Pharmaceutical, Inc.	$14.79	04/03/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1119105862	Otsuka America Pharmaceutical, Inc.	$24.74	05/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1119105864	Otsuka America Pharmaceutical, Inc.	$6.99	05/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1119105866	Otsuka America Pharmaceutical, Inc.	$13.70	09/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1119105868	Otsuka America Pharmaceutical, Inc.	$16.17	10/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1119105870	Otsuka America Pharmaceutical, Inc.	$17.04	11/13/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1119105872	Otsuka America Pharmaceutical, Inc.	$6.32	12/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1119105874	Otsuka America Pharmaceutical, Inc.	$1.91	12/13/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1120525442	Alkermes, Inc.	$18.76	03/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1143517877	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$14.70	05/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1143517881	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$25.58	07/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1143517885	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$18.44	08/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1143517889	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$23.17	09/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1144557605	Indivior Inc.	$27.63	01/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1144557607	Indivior Inc.	$28.81	02/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1144557609	Indivior Inc.	$31.57	04/11/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1144557611	Indivior Inc.	$44.16	05/16/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1144557613	Indivior Inc.	$29.61	07/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146041584	Lundbeck LLC	$26.97	03/14/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146041586	Lundbeck LLC	$22.64	04/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146041588	Lundbeck LLC	$24.47	05/29/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1147893803	Supernus Pharmaceuticals, Inc.	$37.93	07/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150950457	Neurocrine Biosciences, Inc.	$26.28	11/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150954615	Neurocrine Biosciences, Inc.	$25.13	12/20/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150956814	Neurocrine Biosciences, Inc.	$24.60	04/25/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150967779	Neurocrine Biosciences, Inc.	$22.35	10/31/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150970201	Neurocrine Biosciences, Inc.	$21.90	01/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150979944	Neurocrine Biosciences, Inc.	$19.96	03/22/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150980524	Neurocrine Biosciences, Inc.	$19.85	05/24/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150984775	Neurocrine Biosciences, Inc.	$19.01	07/29/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1151025203	Neurocrine Biosciences, Inc.	$3.79	01/31/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1151025647	Neurocrine Biosciences, Inc.	$3.40	08/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1151561318	Teva Pharmaceuticals USA, Inc.	$8.61	01/25/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1151561320	Teva Pharmaceuticals USA, Inc.	$4.33	01/31/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1151561332	Teva Pharmaceuticals USA, Inc.	$4.85	03/13/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1151561334	Teva Pharmaceuticals USA, Inc.	$1.65	03/14/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1151561336	Teva Pharmaceuticals USA, Inc.	$8.27	03/14/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1151561338	Teva Pharmaceuticals USA, Inc.	$22.20	04/11/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1151561364	Teva Pharmaceuticals USA, Inc.	$22.14	05/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1151561380	Teva Pharmaceuticals USA, Inc.	$13.55	05/29/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1151561400	Teva Pharmaceuticals USA, Inc.	$20.43	07/17/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1151561402	Teva Pharmaceuticals USA, Inc.	$18.52	08/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1151561414	Teva Pharmaceuticals USA, Inc.	$6.20	08/27/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS

Provenance & corrections

Dataset: CMS Open Payments — General Payments
Source: CMS Open Payments dataset (bulk file)
Publisher of source data: Centers for Medicare & Medicaid Services
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.